Picture of Palisade Bio logo

PALI — Palisade Bio News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Palisade Bio Cleared By Health Canada To Commence Phase 1 Clinical Study

Oct 10 (Reuters) - Palisade Bio Inc  PALI.O :
    * PALISADE BIO CLEARED BY HEALTH CANADA TO COMMENCE PHASE 1
CLINICAL STUDY FOR LEAD PROGRAM, PALI-2108 FOR THE TREATMENT OF
ULCERATIVE COLITIS (UC)
    * PALISADE BIO INC - ON TRACK COMMENCE SITE INITIATION AND
ENROLLMENT FOR STUDY BEFORE YEAR END

Source text for Eikon:  ID:nGNXzDPDc 
Further company coverage:  PALI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Palisade Bio

See all news